SCHEMBL645832

SCHEMBL645832

CN(Cc1cccnc1)S(=O)(=O)c1cc(-c2nnc(O)n2-c2ccccc2Cl)c(O)cc1O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.48
TDP1 Q9NUW8 1/20 0.39
NR1H4 Q96RI1 1/20 0.37
PDK1 Q15118 3/20 0.37
NAMPT P43490 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
HSP90AB1 P08238 1/20 0.36
NOX4 Q9NPH5 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
POLB P06746 1/20 0.35
TP53 P04637 1/20 0.35
GPBAR1 Q8TDU6 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL644540 0.91 HSP90AA1 (0.43) HSP90AA1TDP1NAMPTHSP90AB1PDE4A
SCHEMBL646966 0.91 HSP90AA1 (0.52) HSP90AA1ALDH1A1HPGDHSP90AB1POLB
SCHEMBL645746 0.90 HSP90AA1 (0.51) HSP90AA1TDP1NAMPTALDH1A1HPGD
SCHEMBL646372 0.90 HSP90AA1 (0.50) HSP90AA1PDK1NAMPTALDH1A1HPGD
SCHEMBL646245 0.88 HSP90AA1 (0.49) HSP90AA1ALDH1A1HPGDHSP90AB1POLB
SCHEMBL644619 0.88 HSP90AA1 (0.49) HSP90AA1ALDH1A1HPGDHSP90AB1POLB
SCHEMBL646667 0.88 HSP90AA1 (0.51) HSP90AA1ALDH1A1HPGDHSP90AB1POLB
SCHEMBL646663 0.87 HSP90AA1 (0.47) HSP90AA1TDP1ALDH1A1POLB
SCHEMBL646690 0.86 HSP90AA1 (0.48) HSP90AA1TDP1NAMPTALDH1A1HPGD
SCHEMBL647209 0.86 HSP90AA1 (0.49) HSP90AA1POLBTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2023922-B1 TRIAZOLE DERIVATIVES II MERCK PATENT GMBH (DE) 2012-07-11 EP claimed
US-8119795-B2 Triazole derivatives II MERCK PATENT GMBH (DE) 2012-02-21 US claimed
US-20100022540-A1 TRIAZOLE DERIVATIVES II MERCK PATENT GESELLSCHAFT (DE) 2010-01-28 US claimed
EP-2023922-B1 TRIAZOLE DERIVATIVES II MERCK PATENT GMBH (DE) 2012-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022540-A1 TRIAZOLE DERIVATIVES II HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885TDP1 1243/4885NR1H4 473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.